FDG-PET/CT tumor to liver SUV ratio (TLR), tumor SUVmax, and tumor size: can this help in differentiating squamous cell carcinoma from adenocarcinoma of the lung?

[1] Volpi S(2018)The role of positron emission tomography in the diagnosis, staging, and response assessment of non-small cell lung cancer Ann Transl Med 6 95-103

[2] Ali JM(2014)Cancer statistics, 2014 CA Cancer J Clin 64 9-29

[3] Tasker A(2019)Global epidemiology of lung cancer Ann Glob Health 85 1-16

[4] Siegel R(2019)Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma Br J Radiol 92 20180792-451

[5] Ma J(2020)The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients Eur Radiol 30 442-285

[6] Zou Z(2011)The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification J Thoracic Oncol 6 244-292

[7] Barta JA(2018)Complications of CT-guided transthoracic lung biopsy: a short report on current literature and a case of systemic air embolism Wien Klin Wochenschr 130 288-2929

[8] Powell CA(2019)Bleeding risk of transbronchial cryobiopsy compared to transbronchial forceps biopsy in interstitial lung disease—a prospective, randomized, multicentre cross-over trial Respir Res 20 140-632

[9] Wisnivesky JP(2013)FDG PET-CT in non-small cell lung cancer: the relationship between primary tumor FDG uptake and extensional or metastatic potential Asian Pac J Cancer Prev 14 2925-2999

[10] Messerli M(2013)PET–CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology Lung 191 625-714

[1] Volpi S(2018)The role of positron emission tomography in the diagnosis, staging, and response assessment of non-small cell lung cancer Ann Transl Med 6 95-103

[2] Ali JM(2014)Cancer statistics, 2014 CA Cancer J Clin 64 9-29

[3] Tasker A(2019)Global epidemiology of lung cancer Ann Glob Health 85 1-16

[4] Siegel R(2019)Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma Br J Radiol 92 20180792-451

[5] Ma J(2020)The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients Eur Radiol 30 442-285

[6] Zou Z(2011)The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification J Thoracic Oncol 6 244-292

[7] Barta JA(2018)Complications of CT-guided transthoracic lung biopsy: a short report on current literature and a case of systemic air embolism Wien Klin Wochenschr 130 288-2929

[8] Powell CA(2019)Bleeding risk of transbronchial cryobiopsy compared to transbronchial forceps biopsy in interstitial lung disease—a prospective, randomized, multicentre cross-over trial Respir Res 20 140-632

[9] Wisnivesky JP(2013)FDG PET-CT in non-small cell lung cancer: the relationship between primary tumor FDG uptake and extensional or metastatic potential Asian Pac J Cancer Prev 14 2925-2999

[10] Messerli M(2013)PET–CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology Lung 191 625-714